✦ LIBER ✦

Implications of Plasma Protein Binding for Pharmacokinetics and Pharmacodynamics of the -Secretase Inhibitor RO4929097

✍ Scribed by Li, J.; Wu, J.; LoRusso, P. M.; Matherly, L. H.

Book ID: 111931942
Publisher: American Association for Cancer Research
Year: 2012
Tongue: English
Weight: 853 KB
Volume: 18
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-11-2684

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The implications of non-linear red blood

The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine

✍ E. SNOECK; P. JACQMIN; A. VAN PEER; M. DANHOF; K. VER DONCK; H. VAN BELLE; R. WO 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 833 KB

Implications of dose regimen and protein

Implications of dose regimen and protein binding for plasma nortriptyline estimations

✍ I.H. Stevenson; Nina M. Wilson; A.A. Schiff 📂 Article 📅 1978 🏛 Elsevier Science 🌐 English ⚖ 376 KB

A mechanism-based binding model for the

A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab

✍ Naoto Hayashi; Yuko Tsukamoto; William M. Sallas; Philip J. Lowe 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

Plasma Protein Biomarkers as Indicators

Plasma Protein Biomarkers as Indicators of Pharmacokinetics and Pharmacodynamics in the Development of Novel Cancer Drugs

✍ Kenneth D. Tew 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Effect of Hepatic Disease on the Pharmac

Effect of Hepatic Disease on the Pharmacokinetics and Plasma Protein Binding of Eprosartan

✍ David Tenero; David Martin; Martha Chapelsky; Bernard Ilson; Steven Boike; Scott 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

Pharmacokinetics and protein binding of

Pharmacokinetics and protein binding of the selective neuronal nitric oxide synthase inhibitor 7-nitroindazole

✍ Mark A. Bush; Gary M. Pollack 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract Utilization of nitric oxide (NO) synthase (NOS) inhibitors to probe the role of NO in various central nervous system processes requires use of an inhibitor selective for neuronal NOS, and is facilitated by knowledge of the pharmacokinetics of the inhibitor. The present project was under